Simplex Trading’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$151K | – | 11040 |
|
|
2022
Q3 | $151K | Buy |
+10,000
| New | +$116K | ﹤0.01% | 4982 |
|
|
2022
Q2 | – | Sell |
-5,000
| Closed | -$45K | – | 11598 |
|
|
2022
Q1 | $45K | Sell |
5,000
-600
| -11% | -$4.63K | ﹤0.01% | 7294 |
|
|
2021
Q4 | $39K | Buy |
5,600
+3,500
| +167% | +$36.6K | ﹤0.01% | 7582 |
|
|
2021
Q3 | $34K | Hold |
2,100
| – | – | ﹤0.01% | 7984 |
|
|
2021
Q2 | $33K | Buy |
2,100
+2,089
| +18,991% | +$35.8K | ﹤0.01% | 8158 |
|
|
2021
Q1 | $19K | Sell |
11
-63
| -85% | -$1.09K | ﹤0.01% | 7511 |
|
|
2020
Q4 | $99K | Buy |
74
+2
| +3% | +$24 | ﹤0.01% | 5458 |
|
|
2020
Q3 | $84K | Buy |
72
+61
| +555% | +$743 | ﹤0.01% | 5093 |
|
|
2020
Q2 | $16K | Sell |
11
-53
| -83% | -$784 | ﹤0.01% | 6390 |
|
|
2020
Q1 | $86K | Sell |
64
-119
| -65% | -$2.26K | ﹤0.01% | 4536 |
|
|
2019
Q4 | $442K | Sell |
183
-188
| -51% | -$3.89K | ﹤0.01% | 2878 |
|
|
2019
Q3 | $713K | Buy |
371
+103
| +38% | +$2.36K | ﹤0.01% | 2273 |
|
|
2019
Q2 | $791K | Buy |
268
+144
| +116% | +$5.55K | ﹤0.01% | 2123 |
|
|
2019
Q1 | $589K | Buy |
124
+84
| +210% | +$3.7K | ﹤0.01% | 2491 |
|
|
2018
Q4 | $144K | Sell |
40
-5
| -11% | -$235 | ﹤0.01% | 3492 |
|
|
2018
Q3 | $276K | Sell |
45
-74
| -62% | -$4.76K | ﹤0.01% | 3281 |
|
|
2018
Q2 | $803K | Buy |
119
+113
| +1,883% | +$6.32K | ﹤0.01% | 1987 |
|
|
2018
Q1 | $1K | Sell |
6
-170
| -97% | -$9.51K | ﹤0.01% | 5884 |
|
|
2017
Q4 | $79K | Buy |
176
+159
| +935% | +$9.64K | ﹤0.01% | 2014 |
|
|
2017
Q3 | $4K | Sell |
17
-117
| -87% | -$6.38K | ﹤0.01% | 4650 |
|
|
2017
Q2 | $13K | Buy |
134
+113
| +538% | +$5.26K | ﹤0.01% | 3764 |
|
|
2017
Q1 | $1K | Sell |
21
-322
| -94% | -$14.4K | ﹤0.01% | 5877 |
|
|
2016
Q4 | $121K | Sell |
343
-433
| -56% | -$16.4K | 0.01% | 1387 |
|
|
2016
Q3 | $88K | Buy |
776
+626
| +417% | +$13.8K | 0.01% | 1622 |
|
|
2016
Q2 | $85K | Buy |
150
+149
| +14,900% | +$2.41K | 0.01% | 1606 |
|
|
2016
Q1 | $1K | Sell |
1
-8
| -89% | -$127 | ﹤0.01% | 5298 |
|
|
2015
Q4 | $1K | Sell |
9
-104
| -92% | -$2.43K | ﹤0.01% | 5071 |
|
|
2015
Q3 | $46K | Sell |
113
-299
| -73% | -$5.42K | ﹤0.01% | 2063 |
|
|
2015
Q2 | $139K | Buy |
412
+376
| +1,044% | +$6.89K | 0.01% | 1007 |
|
|
2015
Q1 | $7K | Buy |
+36
| New | +$1.04K | ﹤0.01% | 3263 |
|
Simplex Trading's AERI Position: Q4 2022 in Review
Simplex Trading sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 4,120 shares — an estimated $62K sold.
Simplex Trading first reported a position in AERI in Q2 2015 and held it in 23 quarters. The position peaked at $1.33M in Q3 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Simplex Trading reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Simplex Trading sold 4,120 Aerie Pharmaceuticals shares in Q4 2022, an estimated $62K.
- Simplex Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 23 quarters.
- Simplex Trading's Aerie Pharmaceuticals position peaked at $1.33M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.